Founder and Chief Executive Officer

Chief Commercial Officer

Morning briefing: Geiger Counter serves notice on Manulife; Government delays Tritax data centre decision; plus BPCR, OCI, PCTN, ASLI

Zenas BioPharma reports Q4 EPS ($4.54) vs. ($1.26) last year

Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight

0.6000000238418579

Associate Director, Medical Science Liaison (MSL), Neurology

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. The Associate Director, Medical Science Liaison (MSL), Neurology, will serve as a key resource for the healthcare community, providing scientifically rigorous information and supporting clinical research activities.

Chairman and CEO

EVP, Chief Commercial Officer

VOR: Telitacicept drives a global autoimmune strategy, backed by strong data, funding, and expert leadership

Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors

Vor Bio Announces $150 Million Private Placement

Vor Biopharma Launches $150 Million Private Placement; Shares Rise

Medical Science Liaison (MSL) Rheumatology

Vor Biopharma is dedicated to tackling autoimmune diseases through innovative therapies. The Medical Science Liaison (MSL) in Rheumatology will serve as a scientific expert, fostering partnerships with healthcare professionals and supporting the development of telitacicept for Sjogren’s Disease.

Medical Science Liaison (MSL) Rheumatology Northern California/Pacific Northwest

Chief Financial Officer

Chief Business Officer

Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals

Forget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline

Nxera Pharma rebuild starting to pay off

Centessa Pharmaceuticals Announces CEO Departure

Senior Medical Science Liaison (MSL) - Northeast

Centessa Pharmaceuticals plc is a new kind of pharmaceutical company focused on data-driven decision making and advancing a portfolio of high conviction programs. The Senior Medical Science Liaison (MSL) will engage with healthcare professionals, support clinical development, and translate complex scientific data into actionable clinical insights.

Medical Science Liaison (MSL) Neurology

Vor Bio is a company dedicated to tackling autoimmune disease at its root by advancing innovative therapies. The Medical Science Liaison (MSL) in Neurology will act as a scientific expert, building partnerships with healthcare professionals and supporting the development of telitacicept for myasthenia gravis.

Medical Science Liaison (MSL) Neurology Texas

Associate Director, Medical Science Liaison (MSL), Rheumatology

Zenas is a clinical-stage global biopharmaceutical company focused on developing transformative therapies for autoimmune diseases. The Associate Director, Medical Science Liaison (MSL) in Rheumatology will serve as a field-based extension of the Medical Affairs department, engaging with healthcare professionals and providing scientific information regarding Zenas' product portfolio.

CEO, Skeletal Dysplasias (QED Therapeutics)

CEO and Founder

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - March 20, 2026

BridgeBio reports Phase III progress for BBP-418

BridgeBio presents Phase 3 FORTIFY interim analysis results

BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9

Senior Medical Science Liaison

BridgeBio is a company pioneering innovative approaches in biotech, focusing on developing life-changing medicines for patients with unmet needs. The Medical Science Liaison (MSL) is responsible for engaging with healthcare professionals and stakeholders, executing territory medical plans, and cultivating relationships within the rare disease therapeutic area.

Medical Science Liaison/Sr. Medical Science Liaison (MSL)

Medical Science Liaison (MSL) Neurology South Central

Vor Bio is focused on redefining the future of autoimmune care through innovative treatments. The Medical Science Liaison (MSL) in Neurology will serve as a scientific expert, fostering partnerships with healthcare professionals and supporting clinical trial execution for telitacicept in Myasthenia Gravis.

Chairman of the Board and Chief Executive Officer

Vice President, Global Strategy and Pipeline, Allergan Aesthetics

Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie

Best Healthcare Stocks to Buy After the Market Pullback

HSBC’s Pharma Stocks that Offer Value & Growth at a Reasonable Price

Protagonist’s First Approval Spells Trouble for Pharma’s Immunology Heavyweights

National Oncology Medical Outcomes Science Liaison (MOSL)

AbbVie is a company dedicated to discovering and delivering innovative medicines that address serious health issues. They are seeking a National Medical Outcomes Science Liaison in Oncology to engage national healthcare access decision makers and facilitate scientific exchange using clinical evidence and health economics to inform product access and decision making.

Executive Vice President, Medical

Form 10-K

Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting

0.800000011920929

Medical Science Liaison (MSL) - Heartland

Tonix Pharmaceuticals is a fully integrated biotechnology company focused on developing therapeutics to treat and prevent human disease. The Medical Science Liaison (MSL) will align scientific expertise with organizational goals to support the commercialization and development of the Company's product portfolio, while establishing relationships with key opinion leaders and healthcare professionals.

Chief Medical Officer

Executive Assistant To Chief Executive Officer

Mineralys Therapeutics' Treatment Fails to Reduce Sleep Apnea

Mineralys Therapeutics Announces FDA Acceptance of NDA for Lorundrostat for Treatment of Adults with Hypertension and Topline Explore-OSA Trial Results

Mineralys Therapeutics Announces FDA Acceptance Of NDA For Lorundrostat For Treatment Of Adults With Hypertension And Topline Explore-Osa Trial Results

Mineralys Therapeutics Provides Corporate Update and Announces Participation in Upcoming LifeSci Partners Corporate Access Event in January 2026

0.4000000059604645

Senior Medical Science Liaison - Cardiovascular

Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities. They are seeking a Senior Medical Science Liaison to support the US Medical Affairs team by establishing relationships with Key Opinion Leaders and Healthcare Practitioners in the New York City Region and Long Island.

Senior Medical Science Liaisons (MSL) - Cardiovascular - US New York City Region/Long Island

Vor BioPharma is dedicated to redefining the future of autoimmune care through innovative science. The Medical Science Liaison (MSL) in Rheumatology will serve as a scientific expert, fostering partnerships with healthcare professionals and supporting clinical trial execution while focusing on advancing telitacicept for Sjogren’s Disease.

Medical Science Liaison (MSL) Rheumatology South Central

Vor Bio is focused on redefining the future of autoimmune care through innovative treatments. They are seeking a Medical Science Liaison (MSL) in Neurology to serve as a scientific expert, fostering partnerships and supporting clinical trials for their leading therapy, telitacicept, particularly in Myasthenia Gravis.

Medical Science Liaison (MSL) Neurology Mid Atlantic

VP of Operations and Chief of Staff to the CEO

Co-founder and CEO

BillionToOne Q4 Revenue More Than Doubles, Firm Enters UnitedHealthcare Network in April

BillionToOne Q4 Revenue More Than Doubles, Firm Raises Full-Year 2026 Revenue Guidance

BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select®

The Healthcare Technology Report Announces The Top Healthcare Technology CEOs of 2025

Medical Science Liaison (MSL), Oncology

BillionToOne is a next-generation molecular diagnostics company focused on making accurate diagnostic tests accessible to everyone. They are seeking a field-based Medical Science Liaison (MSL) in Oncology to support their oncology portfolio of liquid biopsy products by engaging with healthcare providers and key opinion leaders, providing clinical and scientific information, and contributing to educational product development.

Medical Science Liaison (MSL), Oncology (Central)

Medical Science Liaison (msl)   Heartland

Medical Science Liaison (msl) Heartland in united states (1000+)